171 related articles for article (PubMed ID: 16610343)
1. Structural determinants of potassium channel blockade and drug-induced arrhythmias.
Wehrens XH
Handb Exp Pharmacol; 2006; (171):123-57. PubMed ID: 16610343
[TBL] [Abstract][Full Text] [Related]
2. K+ channel structure-activity relationships and mechanisms of drug-induced QT prolongation.
Clancy CE; Kurokawa J; Tateyama M; Wehrens XH; Kass RS
Annu Rev Pharmacol Toxicol; 2003; 43():441-61. PubMed ID: 12540747
[TBL] [Abstract][Full Text] [Related]
3. Studying cardiac arrhythmias in the mouse--a reasonable model for probing mechanisms?
Nerbonne JM
Trends Cardiovasc Med; 2004 Apr; 14(3):83-93. PubMed ID: 15121155
[TBL] [Abstract][Full Text] [Related]
4. The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications.
Thomas D; Karle CA; Kiehn J
Curr Pharm Des; 2006; 12(18):2271-83. PubMed ID: 16787254
[TBL] [Abstract][Full Text] [Related]
5. Expression and coassociation of ERG1, KCNQ1, and KCNE1 potassium channel proteins in horse heart.
Finley MR; Li Y; Hua F; Lillich J; Mitchell KE; Ganta S; Gilmour RF; Freeman LC
Am J Physiol Heart Circ Physiol; 2002 Jul; 283(1):H126-38. PubMed ID: 12063283
[TBL] [Abstract][Full Text] [Related]
6. Familial and acquired long qt syndrome and the cardiac rapid delayed rectifier potassium current.
Witchel HJ; Hancox JC
Clin Exp Pharmacol Physiol; 2000 Oct; 27(10):753-66. PubMed ID: 11022966
[TBL] [Abstract][Full Text] [Related]
7. Molecular biology and cellular mechanisms of Brugada and long QT syndromes in infants and young children.
Antzelevitch C
J Electrocardiol; 2001; 34 Suppl():177-81. PubMed ID: 11781953
[TBL] [Abstract][Full Text] [Related]
8. Molecular determinants of high-affinity drug binding to HERG channels.
Mitcheson JS; Perry MD
Curr Opin Drug Discov Devel; 2003 Sep; 6(5):667-74. PubMed ID: 14579516
[TBL] [Abstract][Full Text] [Related]
9. I(Kr): the hERG channel.
Tseng GN
J Mol Cell Cardiol; 2001 May; 33(5):835-49. PubMed ID: 11343409
[TBL] [Abstract][Full Text] [Related]
10. Rb+ efflux through functional activation of cardiac KCNQ1/minK channels by the benzodiazepine R-L3 (L-364,373).
Jow F; Tseng E; Maddox T; Shen R; Kowal D; Dunlop J; Mekonnen B; Wang K
Assay Drug Dev Technol; 2006 Aug; 4(4):443-50. PubMed ID: 16945016
[TBL] [Abstract][Full Text] [Related]
11. Effects of the antifungal antibiotic clotrimazole on human cardiac repolarization potassium currents.
Tian M; Dong MQ; Chiu SW; Lau CP; Li GR
Br J Pharmacol; 2006 Feb; 147(3):289-97. PubMed ID: 16341233
[TBL] [Abstract][Full Text] [Related]
12. Structural determinants and biophysical properties of HERG and KCNQ1 channel gating.
Tristani-Firouzi M; Sanguinetti MC
J Mol Cell Cardiol; 2003 Jan; 35(1):27-35. PubMed ID: 12623297
[TBL] [Abstract][Full Text] [Related]
13. Modulation of HERG potassium channel function by drug action.
Thomas D; Karle CA; Kiehn J
Ann Med; 2004; 36 Suppl 1():41-6. PubMed ID: 15176423
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cardiac delayed rectifier K+ current by overexpression of the long-QT syndrome HERG G628S mutation in transgenic mice.
Babij P; Askew GR; Nieuwenhuijsen B; Su CM; Bridal TR; Jow B; Argentieri TM; Kulik J; DeGennaro LJ; Spinelli W; Colatsky TJ
Circ Res; 1998 Sep; 83(6):668-78. PubMed ID: 9742063
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of cardiac potassium channels.
Tamargo J; Caballero R; Gómez R; Valenzuela C; Delpón E
Cardiovasc Res; 2004 Apr; 62(1):9-33. PubMed ID: 15023549
[TBL] [Abstract][Full Text] [Related]
16. Dysfunction of delayed rectifier potassium channels in an inherited cardiac arrhythmia.
Sanguinetti MC
Ann N Y Acad Sci; 1999 Apr; 868():406-13. PubMed ID: 10414310
[TBL] [Abstract][Full Text] [Related]
17. Subcellular localization of the delayed rectifier K(+) channels KCNQ1 and ERG1 in the rat heart.
Rasmussen HB; Møller M; Knaus HG; Jensen BS; Olesen SP; Jørgensen NK
Am J Physiol Heart Circ Physiol; 2004 Apr; 286(4):H1300-9. PubMed ID: 14670813
[TBL] [Abstract][Full Text] [Related]
18. Repolarization of the cardiac action potential. Does an increase in repolarization capacity constitute a new anti-arrhythmic principle?
Grunnet M
Acta Physiol (Oxf); 2010 Feb; 198 Suppl 676():1-48. PubMed ID: 20132149
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of cardiac potassium channels.
Li GR; Dong MQ
Adv Pharmacol; 2010; 59():93-134. PubMed ID: 20933200
[TBL] [Abstract][Full Text] [Related]
20. KCNE2 confers background current characteristics to the cardiac KCNQ1 potassium channel.
Tinel N; Diochot S; Borsotto M; Lazdunski M; Barhanin J
EMBO J; 2000 Dec; 19(23):6326-30. PubMed ID: 11101505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
